Litcius/Paper detail

Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial

Sady Alpizar, José Accini, Duane C. Anderson, Basem Eysa, Isaí Medina-Piñón, Norio Ohmagari, Мykola Ostrovskyy, Angela Aggrey-Amable, Karen Beck, Dana Byrne, Staci Grayson, Peggy Hwang, Julia Lonchar, Julie Strizki, Yayun Xu, Amanda Paschke, Carisa S De Anda, P.S. Sears

2023Journal of Infection23 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Randomized controlled trial2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PlaceboMedicinePandemicBetacoronavirusIntensive care medicineInternal medicineVirologyAlternative medicinePathologyOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies
Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial | Litcius